Quotes with Resistance & Support
Market Information

Buy Divis Labs, target of Rs 1370: Hem Securities

Posted on: June 25th 2009 in Brokerage Recommendations.

Hem Securities has initiated a buy rating on Divi’s Laboratories with a target price of Rs 1370 in its research report. “Being a pioneer in the API and CRAMS segment, Divi’s Laboratories has posted tremendous growth over the past few years. With the leadership in dextrometh…

Read More..

read more

Breakouts

+ve 30 DMA    50 DMA    150 DMA    200 DMA
-ve 30 DMA    50 DMA    150 DMA    200 DMA

Latest Query

Samrudhiglobal.com wishing you and your friends and family Advance xmas and Happy New year...view more »
- by Sam
Status: Awaiting reply

Market Stats

Search Our Archives

Latest Investment Idea

Recent Comments